Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
JPRN |
Last refreshed on:
|
17 October 2023 |
Main ID: |
JPRN-UMIN000012478 |
Date of registration:
|
01/01/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Open label trial for efficacy and safety of Hydroxychloroquine for systemic lupus erythematosus
|
Scientific title:
|
Open label trial for efficacy and safety of Hydroxychloroquine for systemic lupus erythematosus - Hydroxychloroquine for systemic lupus erythematosus |
Date of first enrolment:
|
2014/04/01 |
Target sample size:
|
10 |
Recruitment status: |
Recruiting |
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014604 |
Study type:
|
Interventional |
Study design:
|
Single arm Non-randomized
|
Phase:
|
Not selected
|
|
Countries of recruitment
|
Japan
| | | | | | | |
Contacts
|
Name:
|
Hajime
Kono |
Address:
|
Kaga 2-11-1, Itabashi-ku, Tyoko173-8605
173-8605
Japan |
Telephone:
|
03-3964-1211 |
Email:
|
kono@med.teikyo-u.ac.jp |
Affiliation:
|
Department of Internal Medicine, Teikyo University School of Medicine Rheumatology and Allergy |
|
Name:
|
Hajime
Kono |
Address:
|
Kaga 2-11-1, Itabashi-ku, Tyoko173-8605
Japan |
Telephone:
|
03-3964-1211 |
Email:
|
kono@med.teikyo-u.ac.jp |
Affiliation:
|
Department of Internal Medicine, Teikyo University School of Medicine Rheumatology and Allergy |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients with severe insufficiency in liver, kidney, heart, bone marrow function. Patients with current or previous history of retinopathy. Patients allergic to 4-aminoquinoline. Other patients who were judged to be ineligible for the study by an attending physician.
Age minimum:
Not applicable
Age maximum:
Not applicable
Gender:
Male and Female
|
Health Condition(s) or Problem(s) studied
|
systemic lupus erythematosus cutaneous lupus erythematosus
|
Intervention(s)
|
Treatment with Hydroxychloroquine
|
Primary Outcome(s)
|
CLASI score
|
Source(s) of Monetary Support
|
None
|
Ethics review
|
Status: YES
Approval date: 31/03/2014
Contact:
turb-office@teikyo-u.ac.jp
Teikyo University Ethics Committee
03-3964-1211
turb-office@teikyo-u.ac.jp
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
31/03/2023 |
URL:
|
|
|
|